Thus, expression of PDIA3 on the surface of cancer cells, and potential effects of the direct binding of CSSTRESAC to breast cancer cells warrants further investigation and, if confirmed, might have translational implications in the setting of TNBC, and other human tumors or even non-malignant disorders with a inflammatory component. Here, PDIA3 is linked to breast carcinoma.